Home Sutro Biopharma

Sutro Biopharma

In operation
Post-IPO Round
Developer of Tumor Therapeutic Drugs

Basic Information

Sutro Biopharma is a clinical-stage drug discovery, development, and manufacturing company. Sutro uses precise protein engineering and rational design to advance the next generation of cancer therapies. Our focus is primarily on next-generation cancer and autoimmune therapies—antibody conjugates, bispecific antibodies, and cytokine derivatives. Unconstrained by traditional cell-based discovery methods, we can innovate beyond cellular limitations to design and develop targeted drugs.
Sutro Biopharma, Inc.
SanFrancisco,California,United States of America
51~100 people
January 01, 2003
general@sutrobio.com